Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset) | Zendy

Mònica Millán | Zendy; Sebastián Remollo | Zendy; Helena Quesada | Zendy; Arturo Renú | Zendy; Alejandro Tomasello | Zendy; Priyanka Minhas | Zendy; Natàlia Pérez de la Ossa | Zendy; Marta Rubiera | Zendy; Laura Llull | Zendy; Pedro Cardona | Zendy; Fahad Al-Ajlan | Zendy; María HernándezPérez | Zendy; Zarina Assis | Zendy; Andrew M. Demchuk | Zendy; Tudor Jovin | Zendy; Antoni Dávalos | Zendy

Open Access

Vessel Patency at 24 Hours and Its Relationship With Clinical Outcomes and Infarct Volume in REVASCAT Trial (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset)

Author(s) -

Mònica Millán,

Sebastián Remollo,

Helena Quesada,

Arturo Renú,

Alejandro Tomasello,

Priyanka Minhas,

Natàlia Pérez de la Ossa,

Marta Rubiera,

Laura Llull,

Pedro Cardona,

Fahad Al-Ajlan,

María HernándezPérez,

Zarina Assis,

Andrew M. Demchuk,

Tudor Jovin,

Antoni Dávalos

Publication year - 2017

Publication title -

stroke

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.397

H-Index - 319

eISSN - 1524-4628

pISSN - 0039-2499

DOI - 10.1161/strokeaha.116.015455

Subject(s) - medicine , solitaire cryptographic algorithm , revascularization , thrombolysis , randomized controlled trial , stroke (engine) , occlusion , surgery , odds ratio , myocardial infarction , cardiology , radiology , modified rankin scale , ischemia , ischemic stroke , mechanical engineering , engineering

Higher rates of target vessel patency at 24 hours were noted in the thrombectomy group compared with control group in recent randomized trials. As a prespecified secondary end point, we aimed to assess 24-hour revascularization rates by treatment groups and occlusion site as they related to clinical outcome and 24-hour infarct volume in REVASCAT (Randomized Trial of Revascularization With Solitaire FR Device Versus Best Medical Therapy in the Treatment of Acute Stroke Due to Anterior Circulation Large Vessel Occlusion Presenting Within Eight Hours of Symptom Onset).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research